Number To Know…40
Executive Summary
40% is the approximately how much IVD-related sales will contribute to PerkinElmer's total revenue once the company completes its $1.3bn acquisition of EUROIMMUN, a privately held European specialist in autoimmune, infectious disease and allergy testing.